[1] |
SUNG H, FERLAY J, SIEGEL R L, et al. Global cancer statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3):209-249. doi:10.3322/caac.21660.
|
[2] |
VAN DEN BOORN H G, ABU-HANNA A, HAJ MOHAMMAD N, et al. SOURCE:Prediction models for overall survival in patients with metastatic and potentially curable esophageal and gastric cancer[J]. J Natl Compr Canc Netw, 2021, 19(4):403-410. doi:10.6004/jnccn.2020.7631.
|
[3] |
VAN DEN ENDE T, ABE NIJENHUIS F A, VAN DEN BOORN H G, et al. COMplot,a graphical presentation of complication profiles and adverse effects for the curative treatment of gastric cancer:A systematic review and meta-analysis[J]. Front Oncol, 2019, 9:684. doi:10.3389/fonc.2019.00684.
|
[4] |
NEOPHYTOU C M, PANAGI M, STYLIANOPOULOS T, et al. The role of tumor microenvironment in cancer metastasis:Molecular mechanisms and therapeutic opportunities[J]. Cancers(Basel), 2021, 13(9):2053. doi:10.3390/cancers13092053.
|
[5] |
LEE H, ZHANG Z, KRAUSE H M. Long noncoding RNAs and repetitive elements:Junk or intimate evolutionary partners?[J]. Trends Genet, 2019, 35(12):892-902. doi:10.1016/j.tig.2019.09.006.
|
[6] |
LIU S J, DANG H X, LIM D A, et al. Long noncoding RNAs in cancer metastasis[J]. Nat Rev Cancer, 2021, 21(7):446-460. doi:10.1038/s41568-021-00353-1.
|
[7] |
BAKIR B, CHIARELLA A M, PITARRESI J R, et al. EMT,MET,plasticity,and tumor metastasis[J]. Trends Cell Biol, 2020, 30(10):764-776. doi:10.1016/j.tcb.2020.07.003.
|
[8] |
MCCABE E M, RASMUSSEN T P. lncRNA involvement in cancer stem cell function and epithelial-mesenchymal transitions[J]. Semin Cancer Biol, 2021, 75:38-48. doi:10.1016/j.semcancer.2020.12.012.
|
[9] |
PAN T, YU Z, JIN Z, et al. Tumor suppressor lnc-CTSLP4 inhibits EMT and metastasis of gastric cancer by attenuating HNRNPAB-dependent Snail transcription[J]. Mol Ther Nucleic Acids, 2021, 23:1288-1303. doi:10.1016/j.omtn.2021.02.003.
|
[10] |
LIU L, ZHANG C, WANG J, et al. A high level of lncFGD5-AS1 inhibits epithelial-to-mesenchymal transition by regulating the miR-196a-5p/SMAD6/BMP axis in gastric Cancer[J]. BMC Cancer, 2021, 21(1):453. doi:10.1186/s12885-021-08192-x.
|
[11] |
LV J, ZHANG S, LIU Y, et al. NR2F1-AS1/miR-190a/PHLDB2 induces the epithelial-mesenchymal transformation process in gastric cancer by promoting phosphorylation of AKT3[J]. Front Cell Dev Biol, 2021, 9:688949. doi:10.3389/fcell.2021.688949.
|
[12] |
HU J, WANG M, YANG Y, et al. LncRNA DLEU2 silencing impedes the migration,invasion and EMT in gastric cancer cell by suppressing PI3K/AKT signaling pathway[J]. Immunopharmacol Immunotoxicol, 2022: 44(5):719-731. doi:10.1080/08923973.2022.2078727.
|
[13] |
TAGHEHCHIAN N, ALEMOHAMMAD R, FARSHCHIAN M, et al. Inhibitory role of LINC00332 in gastric cancer progression through regulating cell EMT and stemness[J]. Life Sci, 2022, 305:120759. doi:10.1016/j.lfs.2022.120759.
|
[14] |
LIN H, WANG J, WANG T, et al. The LncRNA MIR503HG/miR-224-5p/TUSC3 signaling cascade suppresses gastric cancer development via modulating ATF6 branch of unfolded protein response[J]. Front Oncol, 2021, 11:708501. doi:10.3389/fonc.2021.708501.
|
[15] |
BIELENBERG D R, ZETTER B R. The contribution of angiogenesis to the process of metastasis[J]. Cancer J, 2015, 21(4):267-273. doi:10.1097/PPO.0000000000000138.
|
[16] |
CARMELIET P, JAIN R K. Molecular mechanisms and clinical applications of angiogenesis[J]. Nature, 2011, 473(7347):298-307. doi:10.1038/nature10144.
|
[17] |
RAZAVI Z S, ASGARPOUR K, MAHJOUBIN-TEHRAN M, et al. Angiogenesis-related non-coding RNAs and gastrointestinal cancer[J]. Mol Ther Oncolytics, 2021, 21:220-241. doi:10.1016/j.omto.2021.04.002.
|
[18] |
XU Y, LI Y, QIU Y, et al. LncRNA NEAT1 promotes gastric cancer progression through miR-17-5p/TGFβR2 axis up-regulated angiogenesis[J]. Front Cell Dev Biol, 2021, 9:705697. doi:10.3389/fcell.2021.705697.
|
[19] |
CUI X, ZHANG H, CHEN T, et al. Long noncoding RNA SNHG22 induces cell migration,invasion,and angiogenesis of gastric cancer cells via microRNA-361-3p/HMGA1/Wnt/β-Catenin axis[J]. Cancer Manag Res, 2020, 12:12867-12883. doi:10.2147/CMAR.S281578.
|
[20] |
LUO Q, WANG J, ZHAO W, et al. Vasculogenic mimicry in carcinogenesis and clinical applications[J]. J Hematol Oncol, 2020, 13(1):19. doi:10.1186/s13045-020-00858-6.
|
[21] |
ZHAO J, WU J, QIN Y, et al. LncRNA PVT1 induces aggressive vasculogenic mimicry formation through activating the STAT3/Slug axis and epithelial-to-mesenchymal transition in gastric cancer[J]. Cell Oncol(Dordr), 2020, 43(5):863-876. doi:10.1007/s13402-020-00532-6.
|
[22] |
JIANG X, WANG J, DENG X, et al. Role of the tumor microenvironment in PD-L1/PD-1-mediated tumor immune escape[J]. Mol Cancer, 2019, 18(1):10. doi:10.1186/s12943-018-0928-4.
|
[23] |
LIU M, SUN Q, WEI F, et al. Comprehensive insights into the effects and regulatory mechanisms of immune cells expressing programmed death-1/programmed death ligand 1 in solid tumors[J]. Cancer Biol Med, 2020, 17(3):626-639. doi:10.20892/j.issn.2095-3941.2020.0112.
|
[24] |
CHEN Z, ZHONG T, LI T, et al. LncRNA SNHG15 modulates gastric cancer tumorigenesis by impairing miR-506-5p expression[J]. Biosci Rep, 2021, 41(7):BSR20204177. doi:10.1042/BSR20204177.
|
[25] |
DANG S, MALIK A, CHEN J, et al. LncRNA SNHG15 contributes to immuno-escape of gastric cancer through targeting miR141/PD-L1[J]. Onco Targets Ther, 2020, 13:8547-8556. doi:10.2147/OTT.S251625.
|
[26] |
WANG C J, ZHU C C, XU J, et al. The lncRNA UCA1 promotes proliferation,migration,immune escape and inhibits apoptosis in gastric cancer by sponging anti-tumor miRNAs[J]. Mol Cancer, 2019, 18(1):115. doi:10.1186/s12943-019-1032-0.
|
[27] |
PEÑA-ROMERO A C, ORENES-PIÑERO E. Dual effect of immune cells within tumour microenvironment:Pro- and anti-tumour effects and their triggers[J]. Cancers(Basel), 2022, 14(7):1681. doi:10.3390/cancers14071681.
|
[28] |
XIE C, GUO Y, LOU S. LncRNA ANCR promotes invasion and migration of gastric cancer by regulating FoxO1 expression to inhibit macrophage M1 polarization[J]. Dig Dis Sci, 2020, 65(10):2863-2872. doi:10.1007/s10620-019-06019-1.
|
[29] |
XIAO X, CHENG W, ZHANG G, et al. Long noncoding RNA:Shining stars in the immune microenvironment of gastric cancer[J]. Front Oncol, 2022, 12:862337. doi:10.3389/fonc.2022.862337.
|
[30] |
ZHANG X, WANG W, ZHU W, et al. Mechanisms and functions of long non-coding RNAs at multiple regulatory levels[J]. Int J Mol Sci, 2019, 20(22):5573. doi:10.3390/ijms20225573.
|
[31] |
YE J, LI J, ZHAO P. Roles of ncRNAs as ceRNAs in gastric cancer[J]. Genes(Basel), 2021, 12(7):1036. doi:10.3390/genes12071036.
|
[32] |
HU Y Z, HU Z L, LIAO T Y, et al. LncRNA SND1-IT1 facilitates TGF-β1-induced epithelial-to-mesenchymal transition via miR-124/COL4A1 axis in gastric cancer[J]. Cell Death Discov, 2022, 8(1):73. doi:10.1038/s41420-021-00793-6.
|
[33] |
HUANGFU L, FAN B, WANG G, et al. Novel prognostic marker LINC00205 promotes tumorigenesis and metastasis by competitively suppressing miRNA-26a in gastric cancer[J]. Cell Death Discov, 2022, 8(1):5. doi:10.1038/s41420-021-00802-8.
|
[34] |
HUANG G, XIANG Z, WU H, et al. The lncRNA BDNF-AS/WDR5/FBXW7 axis mediates ferroptosis in gastric cancer peritoneal metastasis by regulating VDAC3 ubiquitination[J]. Int J Biol Sci, 2022, 18(4):1415-1433. doi:10.7150/ijbs.69454.
|
[35] |
REINA S, GUARINO F, MAGRÌ A, et al. VDAC3 as a potential marker of mitochondrial status is involved in cancer and pathology[J]. Front Oncol, 2016, 6:264. doi:10.3389/fonc.2016.00264.
|
[36] |
OU X, ZHOU X, LI J, et al. p53-induced LINC00893 regulates RBFOX2 stability to suppress gastric cancer progression[J]. Front Cell Dev Biol, 2021, 9:796451. doi:10.3389/fcell.2021.796451.
|
[37] |
ZHANG H, MA R R, ZHANG G, et al. Long noncoding RNA lnc-LEMGC combines with DNA-PKcs to suppress gastric cancer metastasis[J]. Cancer Lett, 2022, 524:82-90. doi:10.1016/j.canlet.2021.09.042.
|
[38] |
JACKSON S, XIONG Y. CRL4s:The CUL4-RING E3 ubiquitin ligases[J]. Trends Biochem Sci, 2009, 34(11):562-570. doi:10.1016/j.tibs.2009.07.002.
|
[39] |
LIU H T, ZOU Y X, ZHU W J, et al. LncRNA THAP7-AS1,transcriptionally activated by SP1 and post-transcriptionally stabilized by METTL3-mediated m6A modification,exerts oncogenic properties by improving CUL4B entry into the nucleus[J]. Cell Death Differ, 2022, 29(3):627-641. doi:10.1038/s41418-021-00879-9.
|
[40] |
WEI S, DAI S, ZHANG C, et al. LncRNA NR038975,a serum-based biomarker,promotes gastric tumorigenesis by interacting with NF90/NF45 complex[J]. Front Oncol, 2021, 11:721604. doi:10.3389/fonc.2021.721604.
|